ViewRay (NASDAQ: VRAY) is a publically held company that develops advanced radiation therapy technology for the treatment of cancer. The MRIdian® system provides continuous soft-tissue imaging during treatment, using MRI-guided radiation therapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient’s anatomy.

News: ViewRay Receives Japanese Regulatory Approval for MRIdian Linac System